Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life.
The aim of this study was to evaluate the carcinogenic risks associated with radiation in mass mammographic screening. Assessment was in terms of breast cancer mortality and years of life for a hypothetical cohort of 100 000 women. Data were obtained on incidence, mortality and life expectancy for the female population of Stockholm. With a screening interval of 18 months at ages 40-49 years, a total absorbed dose to the breast of 13 mGy per invited woman; and an annual breast cancer reduction of 25% per year 7 years from screening start, the net number of years gained was at least 2800. However, using the highest absorbed dose reported in routine mammographic screening in Sweden (approximately 3 mGy per view), and the highest reported radiation risk in the literature, a programme entailing annual screening with 2 views would require at least a 20% annual reduction in breast cancer mortality to give a net benefit in both the number of years of life gained and number of breast cancer deaths avoided. This observation supports the conclusion that exposures with low absorbed dose are essential when performing mass screening with mammography among young women.
Mattsson
A
A
Oncologic Centre, Karolinska University Hospital, Stockholm, Sweden.
Leitz
W
W
Rutqvist
L E
LE
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology / Q000401:mortality* / Q000517:prevention & control; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008017:Life Expectancy; D008327:Mammography / Q000009:adverse effects*; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000401:mortality*; D011829:Radiation Dosage; D013548:Sweden / Q000453:epidemiology